Quest Diagnostics
DGX
#1094
Rank
C$28.25 B
Marketcap
C$252.64
Share price
-0.87%
Change (1 day)
13.64%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Revenue for Quest Diagnostics (DGX)

Revenue in 2025 (TTM): C$15.25 Billion

According to Quest Diagnostics 's latest financial reports the company's current revenue (TTM ) is C$15.01 Billion. In 2024 the company made a revenue of C$14.16 Billion an increase over the revenue in the year 2023 that were of C$12.27 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Quest Diagnostics from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$15.25 B7.69%
2024 C$14.16 B15.44%
2023 C$12.27 B-8.5%
2022 C$13.41 B-2.46%
2021 C$13.74 B14.26%
2020 C$12.03 B19.25%
2019 C$10.09 B-1.64%
2018 C$10.25 B9.19%
2017 C$9.39 B-6.97%
2016 C$10.09 B-2.84%
2015 C$10.39 B20.47%
2014 C$8.62 B13.42%
2013 C$7.60 B4.85%
2012 C$7.25 B-5.02%
2011 C$7.63 B3.72%
2010 C$7.36 B-6.1%
2009 C$7.84 B-11.01%
2008 C$8.81 B31.78%
2007 C$6.68 B-8.35%
2006 C$7.29 B14.13%
2005 C$6.39 B3.86%
2004 C$6.15 B0.19%
2003 C$6.14 B-5.27%
2002 C$6.48 B12.27%
2001 C$5.77 B12.75%
2000 C$5.12 B61.16%
1999 C$3.18 B41.82%
1998 C$2.24 B2.68%
1997 C$2.18 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
LabCorp
LH
C$19.04 B 26.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
C$27.23 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
C$0.98 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
C$38.01 M-99.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
C$0.31 B-97.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
C$2.86 B-80.91%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands